Baclofen withdrawal is a potentially life-threatening syndrome that develops when someone who has been taking baclofen for an extended period suddenly stops or sharply reduces their dose. Symptoms can range from muscle spasms and anxiety to high fever, seizures, and organ failure. The condition affects people on both oral and intrathecal (pump-delivered) baclofen, though pump-related withdrawal tends to be more dangerous. Because baclofen withdrawal can closely mimic other medical emergencies, it is frequently misdiagnosed, which makes understanding it all the more important.
Why Stopping Baclofen Abruptly Is Dangerous
Baclofen works by activating GABA-B receptors in the brain and spinal cord. These receptors dampen neural activity, which is why the drug is effective at reducing muscle spasticity and, in off-label use, alcohol cravings. When someone takes baclofen regularly, the nervous system adapts to that chemical brake being constantly applied. Remove the brake suddenly and the system rebounds hard. The loss of inhibition on certain neural pathways leads to a surge in activity through dopamine and norepinephrine systems, producing a cascade of symptoms that affect the muscles, the autonomic nervous system, and the brain itself.1PubMed Central. Severe Case of Oral Baclofen Withdrawal Resulting in Mechanical Ventilation
This rebound is not just uncomfortable. A review of literature reports and FDA MedWatch data described the intrathecal baclofen withdrawal syndrome as producing high fever, altered mental status, and profound muscular rigidity that sometimes progressed to fatal rhabdomyolysis.2PubMed. Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome The risk is real at any dose level and with any route of delivery. A narrative review covering both oral and intrathecal baclofen emphasized that while these complications can develop with either route, the risk is greater with intrathecal delivery.3PubMed Central. Baclofen therapeutics, toxicity, and withdrawal: A narrative review
Symptoms and How Quickly They Appear
Withdrawal symptoms typically begin within one to four days after baclofen is stopped or significantly reduced.4PubMed. Clinical Presentations and Treatment of Baclofen Toxicity and Withdrawal: A Systematic Review The early signs often include increased muscle spasticity, tremors, itching, and anxiety. From there, symptoms can escalate rapidly.
The full spectrum of baclofen withdrawal includes:
- Muscular: Severe spasms, rigidity, and in worst cases rhabdomyolysis, where muscle tissue breaks down and floods the bloodstream with proteins that can damage the kidneys.
- Neurological: Seizures, altered mental status, confusion, and sedation progressing to coma.
- Psychiatric: Hallucinations, delusions, agitation, and delirium. A systematic review found severe psychiatric disturbances in roughly one in five cases of baclofen withdrawal.5PubMed. Clinical Presentations and Treatment of Baclofen Toxicity and Withdrawal: A Systematic Review
- Autonomic: High fever (hyperpyrexia), rapid heart rate, unstable blood pressure, and excessive sweating.
Symptoms usually peak within the first one to three days, but the situation can become fulminant if not recognized and treated early.6PubMed. Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome In one published case, a 62-year-old woman whose oral baclofen was simply not continued after she was transferred to a skilled nursing facility developed altered mental status and respiratory failure severe enough to require intensive care.7PubMed Central. Oral Baclofen Withdrawal Resulting in Progressive Weakness and Sedation Requiring Intensive Care Admission Another oral baclofen case progressed to the point where the patient needed mechanical ventilation, with a presentation resembling neuroleptic malignant syndrome.8PubMed Central. Severe Case of Oral Baclofen Withdrawal Resulting in Mechanical Ventilation
Oral Versus Intrathecal Withdrawal
People sometimes assume that only patients on intrathecal baclofen pumps are at risk. That is wrong. Abrupt cessation of baclofen, regardless of how the patient receives it, can trigger withdrawal.9PubMed Central. Oral Baclofen Withdrawal Resulting in Progressive Weakness and Sedation Requiring Intensive Care Admission That said, there are meaningful differences between the two routes.
With oral baclofen, withdrawal usually happens because a prescription runs out, a hospital or nursing facility fails to continue the medication, or a patient decides to stop on their own. The onset can be somewhat slower because there is still some drug circulating in the body from the last oral dose, but this does not make it safe. Cases of oral withdrawal requiring ICU admission and ventilator support are well documented in the literature.
Intrathecal withdrawal tends to be more severe because the drug is delivered directly into the spinal fluid at very precise doses. When delivery is interrupted, the concentration at the site of action drops to near zero faster than it would with oral dosing. A case involving a 24-year-old man with cerebral palsy illustrated how devastating this can be: after his pump malfunctioned, he developed hyperthermia, disseminated intravascular coagulation, rhabdomyolysis, acute kidney failure, and multiorgan system failure.10PubMed Central. Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: a case report
When the Pump Fails
For people with intrathecal baclofen pumps, one of the scariest aspects of withdrawal is that it can happen without the patient or their caregiver doing anything wrong. The pump itself or the catheter that delivers the drug can fail mechanically. A study examining unusual pump failures identified several causes: incorrect filling of the pump with the wrong concentration of baclofen, mechanical malfunction of the pump motor, and catheter problems such as dislocation, kinking, obstruction, or the catheter tip ending up in the wrong position.11PubMed Central. Unusual mechanical failures of intrathecal baclofen pump systems: symptoms, signs, and trouble shooting
Any of these problems can silently cut off baclofen delivery. Because the pump is implanted and the patient cannot see what is happening internally, the first sign of a malfunction is often the return of spasticity or the onset of withdrawal symptoms. This is why patients with intrathecal baclofen pumps need regular follow-up appointments to check pump function, refill the reservoir on schedule, and ensure the catheter is intact. Missing a refill appointment is one of the most common and preventable causes of intrathecal withdrawal.
How Baclofen Withdrawal Gets Misdiagnosed
The symptoms of baclofen withdrawal overlap heavily with several other medical emergencies, which means clinicians who are not thinking about the patient’s medication history can easily go down the wrong diagnostic path. A review of 23 published cases of psychiatric symptoms during baclofen withdrawal found that delirium, not other psychiatric conditions, was the consistent pattern. The vulnerability to this delirium appeared greatest in people who had been on chronic baclofen therapy.12PubMed Central. Baclofen therapeutics, toxicity, and withdrawal: A narrative review Cases have been mistaken for meningoencephalitis, seizure disorders, and neuroleptic malignant syndrome.13PubMed Central. Severe Case of Oral Baclofen Withdrawal Resulting in Mechanical Ventilation
An especially tricky scenario arises in patients who take baclofen for alcohol use disorder, an increasingly common off-label application. In these patients, baclofen withdrawal produces confusion, agitation, seizures, and delirium, which is exactly what alcohol withdrawal looks like. A report describing three such cases found that all were initially diagnosed and treated as alcohol withdrawal, with limited effect from benzodiazepines. Only retrospectively was the true cause identified as baclofen withdrawal.14Journal of Clinical Psychopharmacology. Assessing Alcohol Versus Baclofen Withdrawal Syndrome in Patients Treated With Baclofen for Alcohol Use Disorder This distinction matters because the treatment is different: alcohol withdrawal generally responds well to benzodiazepines alone, while baclofen withdrawal requires restarting baclofen.
The practical takeaway for patients and their families: any time someone on baclofen develops sudden confusion, fever, muscle rigidity, or agitation, baclofen withdrawal should be on the list of possible causes. Carrying an information card that lists baclofen as a current medication can be genuinely life-saving, particularly for pump patients who arrive at emergency departments unable to communicate.
Treatment and Emergency Management
The single most effective treatment for baclofen withdrawal is restarting baclofen. This is consistent across the literature. A systematic review found that rapid baclofen reinitiation consistently resolved withdrawal symptoms.15PubMed. Clinical Presentations and Treatment of Baclofen Toxicity and Withdrawal: A Systematic Review When the original route of delivery cannot be restored immediately, such as when an intrathecal pump has failed and needs surgical repair, oral baclofen can be given as a bridge, though doses need to be substantially higher by mouth to approximate the effect of intrathecal delivery.
For intrathecal withdrawal, expert consensus guidelines recommend treating in a monitored setting and restoring intrathecal baclofen delivery as the primary goal. In cases where withdrawal has already been going on for a short time, the previous dosing schedule can simply be restarted. For longer-duration withdrawal, oral baclofen at 10 to 20 milligrams every six hours has been recommended as a stopgap. Supportive care includes maintaining the airway, breathing, and circulation, and seizure prevention should be considered. In some situations, cerebrospinal fluid drainage or sequential lumbar punctures may be needed.16PubMed. Best Practices for Intrathecal Baclofen Therapy: Troubleshooting
When baclofen alone is not enough to control the acute situation, other medications are added. Benzodiazepines are the most commonly used adjunct. A review of intrathecal withdrawal cases found that ICU-based continuous benzodiazepine infusion with careful dose adjustment led to controlled clinical situations and the best patient outcomes.17PubMed Central. In Support of Initial Parenteral Medical Management of Intrathecal Baclofen Withdrawal in Spasticity Patients Low-dose propofol has also been used successfully in selected cases. Other pharmacologic adjuncts may be required depending on the severity of specific symptoms like fever or rigidity.18PubMed Central. Baclofen therapeutics, toxicity, and withdrawal: A narrative review
How to Prevent Baclofen Withdrawal
Prevention is straightforward in principle but easy to fail in practice. The core rule is simple: never stop baclofen abruptly. When it is time to discontinue the medication, the dose should be tapered gradually over weeks, not days. There is no universally agreed-upon taper schedule because the appropriate rate depends on how long the patient has been on baclofen, what dose they are taking, and whether they are on oral or intrathecal therapy.
For intrathecal pump patients, prevention also means keeping pump refill appointments on schedule and having a plan for what to do if the pump alarms or symptoms of increased spasticity emerge between appointments. Anyone involved in the care of a pump patient, whether hospital staff, nursing facility personnel, or family caregivers, needs to understand that abrupt loss of intrathecal baclofen is a medical emergency, not a minor inconvenience.
The most common real-world failure point is transitions in care. When a patient is admitted to a hospital or moved to a rehabilitation facility and their home medications are not properly reconciled, baclofen can slip through the cracks. The cases in the literature repeatedly involve patients whose baclofen was simply not reordered after a transfer.19PubMed Central. Oral Baclofen Withdrawal Resulting in Progressive Weakness and Sedation Requiring Intensive Care Admission Patients and their advocates should proactively verify that baclofen appears on the medication list any time care settings change.
Baclofen Withdrawal in Newborns
A lesser-known scenario involves neonates born to mothers who take baclofen during pregnancy. Baclofen crosses the placenta, so the fetus is exposed throughout gestation. After birth, the baby’s supply of the drug is suddenly cut off, creating the same conditions for withdrawal that exist in adults.
In one case, a male infant born at about 34 weeks to a mother who had been taking 30 milligrams of oral baclofen four times daily throughout pregnancy for spinal cord injury-related spasticity showed concerning posturing movements within 15 minutes of birth. The medical team started a baclofen taper within hours, monitored the infant using a standardized withdrawal scoring tool, and successfully weaned him off by day 14 with no lasting neurological problems.20PubMed. Neonatal baclofen withdrawal following intrauterine exposure
Neonatal baclofen elimination is considerably slower than in adults. A pharmacokinetic study of a full-term newborn exposed to baclofen in utero found that the drug’s half-life in the neonate was about 10 hours, roughly three times longer than in adults.21Neonatology. Pharmacokinetics of Baclofen in a Full-Term Newborn after Intrauterine Exposure: A Case Report This slower clearance means the drug lingers somewhat in the newborn’s system, which in some cases provides a natural gradual taper. In that particular case, the newborn did not develop withdrawal symptoms and was monitored for 11 days. The researchers recommended reducing the mother’s baclofen dose to the lowest effective level before delivery to minimize fetal exposure and withdrawal risk.
The evidence here is still mostly case reports, so there are no firm guidelines on how to manage neonatal baclofen withdrawal. What is clear is that obstetric and neonatal teams need to be aware of the possibility whenever a mother is on baclofen, and that a slow postnatal taper appears to work well when symptoms do emerge.
The Growing Role of High-Dose Baclofen for Alcohol Use Disorder
Baclofen’s off-label use in treating alcohol dependence has been growing, sometimes at doses considerably higher than those used for spasticity. A randomized controlled trial of individually titrated high-dose baclofen for alcohol dependence found the drug effective at helping patients maintain abstinence, with high tolerability and no drug-related serious adverse events during the trial itself.22PubMed. High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial
The withdrawal risk in this population deserves special attention for a couple of reasons. First, these patients may be taking baclofen at doses that produce significant neuroadaptation, meaning the nervous system adjusts more deeply to the drug’s presence and the rebound when it is removed is correspondingly more intense. Second, as discussed earlier, clinicians treating these patients in acute settings may reflexively attribute confusion and seizures to alcohol withdrawal rather than baclofen withdrawal, leading to an incorrect treatment strategy.23Journal of Clinical Psychopharmacology. Assessing Alcohol Versus Baclofen Withdrawal Syndrome in Patients Treated With Baclofen for Alcohol Use Disorder Benzodiazepines alone, the standard treatment for alcohol withdrawal, had limited effect in those misdiagnosed cases. This is a genuinely dangerous knowledge gap in emergency medicine that has only received attention through a handful of case reports so far.
If you are taking baclofen for alcohol cravings or dependence, particularly at higher doses, the same rules apply as for any other baclofen user: do not stop without a taper, make sure every healthcare provider you interact with knows you are on it, and be aware that your withdrawal risk may be elevated if you have been on the drug for months or longer.